Jill Marie Broadfoot A Tyr Pharma Inc (LIFE) insider trading activity

Jill Marie Broadfoot is Chief Financial Officer of aTYR PHARMA INC. Currently has a direct ownership of 27,960 shares of LIFE, which is worth approximately $52,005. The most recent transaction as insider was on May 31, 2024, when has been sold 5,000 shares (Common Stock) at a price of $1.79 per share, resulting in proceeds of $8,950. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28K

0% 3M change

80.85% 12M change

Total Value Held $52,005

Jill Marie Broadfoot Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2024	BUY Open market or private purchase	$8,950 $1.79 p/Share	5,000 Added 15.17%	27,960 Common Stock
Feb 06 2024	SELL Open market or private sale	$2,687 $1.69 p/Share	1,590 Reduced 7.09%	20,821 Common Stock
Feb 05 2024	BUY Exercise of conversion of derivative security	-	3,750 Added 14.33%	22,411 Common Stock
Feb 06 2023	SELL Open market or private sale	$3,695 $2.36 p/Share	1,566 Reduced 9.2%	15,460 Common Stock
Feb 03 2023	BUY Exercise of conversion of derivative security	-	3,750 Added 18.05%	17,026 Common Stock
Jan 13 2022	BUY Open market or private purchase	$12,980 $6.75 p/Share	1,923 Added 13.7%	12,112 Common Stock
Feb 09 2021	SELL Open market or private sale	$2,987 $7.66 p/Share	390 Reduced 3.81%	9,833 Common Stock
Feb 06 2021	BUY Exercise of conversion of derivative security	-	892 Added 8.03%	10,223 Common Stock

Also insider at

OTIC

OTONOMY, INC. Healthcare

Director

ACRX

ACELRX PHARMACEUTICALS INC Healthcare

JMB